Dual antiplatelet therapy (DAPT) is a treatment strategy that involves the use of two medications, typically aspirin and a P2Y12 inhibitor, to reduce the risk of blood clots in patients with cardiovascular conditions like coronary artery disease or after procedures such as stent placement. This approach is crucial for preventing thrombotic events but requires careful management to balance the benefits of clot prevention with the risks of increased bleeding.